Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnauld Verschuur

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Pediatric Blood & Cancer|October 10, 2019
Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC studyGwénaël Le Teuff, Alicia Castaneda-Heredia, Christelle Dufour, et al.
Cancer Medicine|July 27, 2023
Impact of the COVID-19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group studyPrakriti Roy, Sophie E van Peer, Rana Dandis, et al.
Pediatric Blood & Cancer|April 20, 2026
Characteristics and Survival of Patients With Wilms Tumor and Bone Metastases: A SIOP-RTSG 93-01, SIOP 2001, and UK-IMPORT StudyArianna Tagarelli, Rana Dandis, Harm Van Tinteren, et al.
JCO Global Oncology|May 10, 2022
International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and StudyJoaquim Caetano de Aguirre-Neto, Beatriz de Camargo, Harm van Tinteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2026
Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 StudyRhoikos Furtwängler, Rana Dandis, Harm van Tinteren, et al.
JCO Precision Oncology|May 18, 2026
Systematic Review: Prognostic Molecular Biomarkers in Wilms TumorsAgustina Oller, Patrick Kemmeren, Daniela Perotti, et al.
JCO Clinical Cancer Informatics|June 23, 2026
A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG StudiesPrakriti Roy, Ingrid Schut, Norbert Graf, et al.
Nature Reviews. Urology|January 29, 2025
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancersDaniela Perotti, Maureen J O'Sullivan, Amy L Walz, et al.
Plos One|May 26, 2026
Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocolsPaola Quarello, Rana Dandis, Tanzina Chowdhury, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC studyFernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Pediatric Blood & Cancer|October 10, 2019
Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC studyGwénaël Le Teuff, Alicia Castaneda-Heredia, Christelle Dufour, et al.
Cancer Medicine|July 27, 2023
Impact of the COVID-19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group studyPrakriti Roy, Sophie E van Peer, Rana Dandis, et al.
Pediatric Blood & Cancer|April 20, 2026
Characteristics and Survival of Patients With Wilms Tumor and Bone Metastases: A SIOP-RTSG 93-01, SIOP 2001, and UK-IMPORT StudyArianna Tagarelli, Rana Dandis, Harm Van Tinteren, et al.
JCO Global Oncology|May 10, 2022
International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and StudyJoaquim Caetano de Aguirre-Neto, Beatriz de Camargo, Harm van Tinteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2026
Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 StudyRhoikos Furtwängler, Rana Dandis, Harm van Tinteren, et al.
JCO Precision Oncology|May 18, 2026
Systematic Review: Prognostic Molecular Biomarkers in Wilms TumorsAgustina Oller, Patrick Kemmeren, Daniela Perotti, et al.
JCO Clinical Cancer Informatics|June 23, 2026
A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG StudiesPrakriti Roy, Ingrid Schut, Norbert Graf, et al.
Nature Reviews. Urology|January 29, 2025
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancersDaniela Perotti, Maureen J O'Sullivan, Amy L Walz, et al.
Plos One|May 26, 2026
Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocolsPaola Quarello, Rana Dandis, Tanzina Chowdhury, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC studyFernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
Pageof 6